Zelpultide alfa

DB18587InvestigationalProtein Based Therapies

Zelpultide alfa is a recombinant human surfactant protein D.

Mechanism
Curator reviewed
Also known as
HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D (PSPD, SURFACTANT PROTEIN D, SP-D, COLLECTIN-7, SURFACTANT PROTEIN D), NON-COVALENT QUADRUPLE TRIMER, PRODUCED IN HUMAN MYELOGENOUS LEUKEMIA K562 CELLS, GLYCOFORME ALFA · PULMONARY SURFACTANT-ASSOCIATED PROTEIN D (HUMAN RECOMBINANT GLYCOEXPRESS MYELOMA CELL HOMOTRIMERIC QUADRAPLEX AT-100) · PULMONARY SURFACTANT-ASSOCIATED PROTEIN D, RECOMBINANT HUMAN · RECOMBINANT HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D · recombinant human surfactant protein D
Code names
AT-100

Resolves to

Compound
UNII96HS6QEW3XCAS2245003-06-7
Targets
P35247SFTPD

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Zelpultide alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In